← FDA Drug Approvals (Drugs@FDA)

MEMANTINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2022-09-26

Drug application

FDA Application #
ANDA204389
Application type
Abbreviated New Drug Application (Generic)
Brand name
MEMANTINE HYDROCHLORIDE
Generic name
MEMANTINE HYDROCHLORIDE
Active ingredients
MEMANTINE HYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
HETERO LABS LTD V
Manufacturer
Camber Pharmaceuticals, Inc.
First approval
2022-09-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown